Sinaptica hails neuromodulation a “renaissance” in Alzheimer’s treatment
The global neuromodulation device market will be worth $11.4bn by 2033, as per a market model from GlobalData.
Brain-training games remain unproven, but research shows what activities do benefit cognitive functioning
Some 2.3 million of U.S. adults over 65—more than 4%—have a diagnosis of dementia. But even without a diagnosis, a certain ...